GBP5 and ACSS3: two potential biomarkers of high-grade ovarian cancer identified through downstream analysis of microarray data

References

• Aithal, A., Rauth, S., Kshirsagar, P., Shah, A., Lakshmanan, I., Junker, W. M., Jain, M., Ponnusamy, M. P., & Batra, S. K. (2018). MUC16 as a novel target for cancer therapy. Expert Opinion on Therapeutic Targets, 22(8), 675–686. https://doi.org/10.1080/14728222.2018.1498845
   PubMed Web of Science ®Google Scholar
• Aldaz, P., Otaegi-Ugartemendia, M., Saenz-Antoñanzas, A., Garcia-Puga, M., Moreno-Valladares, M., Flores, J. M., Gerovska, D., Arauzo-Bravo, M. J., Samprón, N., Matheu, A., & Carrasco-Garcia, E. (2020). SOX9 promotes tumor progression through the axis BMI1-p21CIP. Scientific Reports, 10(1), 357. https://doi.org/10.1038/s41598-019-57047-w
   PubMed Web of Science ®Google Scholar
• Alonso-López, D., Campos-Laborie, F. J., Gutiérrez, M. A., Lambourne, L., Calderwood, M. A., Vidal, M., & De Las Rivas, J. (2019). APID database: Redefining protein–protein interaction experimental evidences and binary interactomes. Database, 2019. https://doi.org/10.1093/database/baz005
   Google Scholar
• Anjum, A., Jaggi, S., Varghese, E., Lall, S., Bhowmik, A., & Rai, A. (2016). Identification of differentially expressed genes in rna-seq data of Arabidopsis thaliana: A compound distribution approach. Journal of Computational Biology, 23(4), 239–247.
   PubMed Web of Science ®Google Scholar
• Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., Yefanov, A., Lee, H., Zhang, N., Robertson, C. L., Serova, N., Davis, S., & Soboleva, A. (2013). NCBI GEO: Archive for functional genomics data sets—update. Nucleic Acids Research, 41(Database issue), D991–D995.
   PubMed Web of Science ®Google Scholar
• Behera, A., Ashraf, R., Srivastava, A. K., & Kumar, S. (2020). Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells. Heliyon, 6(9), e04820. https://doi.org/10.1016/j.heliyon.2020.e04820
   PubMed Web of Science ®Google Scholar
• Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D. J., Cerny, T., & Thatcher, N. (1996). Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. British Journal of Cancer, 73(3), 294–300.
   PubMed Web of Science ®Google Scholar
• Carbon, S., Ireland, A., Mungall, C. J., Shu, S., Marshall, B., & Lewis, S., Web Presence Working Group. (2009). AmiGO: Online access to ontology and annotation data. Bioinformatics (Oxford, England), 25(2), 288–289.
   PubMed Web of Science ®Google Scholar
• Chen, W.-X., Lou, M., Cheng, L., Qian, Q., Xu, L.-Y., Sun, L., Zhu, Y.-L., & Dai, H. (2019). Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer. Oncology Letters, 18(6), 6017–6025.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Wang, D.-D., Wu, Y.-P., Su, D., Zhou, T.-Y., Gai, R.-H., Fu, Y.-Y., Zheng, L., He, Q.-J., Zhu, H., & Yang, B. (2017). MDM2 promotes epithelial–mesenchymal transition and metastasis of ovarian cancer SKOV3 cells. British Journal of Cancer, 117(8), 1192–1201.
   PubMed Web of Science ®Google Scholar
• Chin, C. H., Chen, S. H., Wu, H. H., Ho, C. W., Ko, M. T., & Lin, C. Y. (2014). cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Systems Biology, 8(Suppl 4), S11. https://doi.org/10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• De Las Rivas, J., & Fontanillo, C. (2010). Protein–protein interactions essentials: key concepts to building and analyzing interactome networks. PLoS Computational Biology, 6(6), e1000807.
   PubMed Web of Science ®Google Scholar
• Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854.
   PubMed Web of Science ®Google Scholar
• Di Benedetto, M., Bièche, I., Deshayes, F., Vacher, S., Nouet, S., Collura, V., Seitz, I., Louis, S., Pineau, P., Amsellem-Ouazana, D., Couraud, P. O., Strosberg, A. D., Stoppa-Lyonnet, D., Lidereau, R., & Nahmias, C. (2006). Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene, 380(2), 127–136. https://doi.org/10.1016/j.gene.2006.05.021
   PubMed Web of Science ®Google Scholar
• Di Palma, T., Lucci, V., de Cristofaro, T., Filippone, M. G., & Zannini, M. (2014). A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells. BMC Cancer, 14(1), 1–8. https://doi.org/10.1186/1471-2407-14-292
   PubMedGoogle Scholar
• Ding, K., Li, W., Zou, Z., Zou, X., & Wang, C. (2014). CCNB1 is a prognostic biomarker for ER + breast cancer. Medical Hypotheses, 83(3), 359–364.
   PubMed Web of Science ®Google Scholar
• Fabregat, A., Sidiropoulos, K., Viteri, G., Marin-Garcia, P., Ping, P., Stein, L., D'Eustachio, P., & Hermjakob, H. (2018). Reactome diagram viewer: Data structures and strategies to boost performance. Bioinformatics (Oxford, England), 34(7), 1208–1214. https://doi.org/10.1093/bioinformatics/btx752
   PubMed Web of Science ®Google Scholar
• Fane, M., Harris, L., Smith, A. G., & Piper, M. (2017). Nuclear factor one transcription factors as epigenetic regulators in cancer. International Journal of Cancer, 140(12), 2634–2641.
   PubMed Web of Science ®Google Scholar
• Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., Whelan, R. J., & Patankar, M. S. (2014). MUC16 (CA125): Tumor biomarker to cancer therapy, a work in progress. Molecular Cancer, 13, 129. https://doi.org/10.1186/1476-4598-13-129
   PubMed Web of Science ®Google Scholar
• Fellenberg, F., Hartmann, T. B., Dummer, R., Usener, D., Schadendorf, D., & Eichmüller, S. (2004). GBP-5 splicing variants: New guanylate-binding proteins with tumor-associated expression and antigenicity. The Journal of Investigative Dermatology, 122(6), 1510–1517. https://doi.org/10.1111/j.0022-202X.2004.22613.x
   PubMed Web of Science ®Google Scholar
• Frenzel, A., Grespi, F., Chmelewskij, W., & Villunger, A. (2009). Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis, 14(4), 584–596. https://doi.org/10.1007/s10495-008-0300-z
   PubMed Web of Science ®Google Scholar
• Gallolu Kankanamalage, S., Karra, A. S., & Cobb, M. H. (2018). WNK pathways in cancer signaling networks. Cell Communication and Signaling, 16(1), 72. https://doi.org/10.1186/s12964-018-0287-1
   PubMedGoogle Scholar
• Gotea, V., & Ovcharenko, I. (2008). DiRE: identifying distant regulatory elements of co-expressed genes. Nucleic Acids Research, 36(Web Server issue), W133–W139. https://doi.org/10.1093/nar/gkn300
   PubMedGoogle Scholar
• Gov, E., & Arga, K. Y. (2017). Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer. Scientific Reports, 7(1), 1–10. https://doi.org/10.1038/s41598-017-05298-w
   PubMedGoogle Scholar
• Guo, H., Guo, J., Xie, W., Yuan, L., & Sheng, X. (2018). The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. Journal of Ovarian Research, 11(1), 1–8. https://doi.org/10.1186/s13048-018-0443-7
   PubMedGoogle Scholar
• Guo, L. L., & Wang, S. F. (2019). Downregulated long noncoding RNA GAS5 fails to function as decoy of CEBPB, resulting in increased GDF15 expression and rapid ovarian cancer cell proliferation. Cancer Biotherapy & Radiopharmaceuticals, 34(8), 537–546. https://doi.org/10.1089/cbr.2019.2889
   PubMed Web of Science ®Google Scholar
• Haga, R. B., & Ridley, A. J. (2016). Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases, 7(4), 207–221. https://doi.org/10.1080/21541248.2016.1232583
   PubMedGoogle Scholar
• He, L. C., Gao, F. H., Xu, H. Z., Zhao, S., Ma, C. M., Li, J., Zhang, S., & Wu, Y. L. (2012). Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma nocarcinoma cells. Oncology Reports, 28(4), 1399–1405. https://doi.org/10.3892/or.2012.1946
   PubMed Web of Science ®Google Scholar
• Hellström, I., Raycraft, J., Hayden-Ledbetter, M., Ledbetter, J. A., Schummer, M., McIntosh, M., Drescher, C., Urban, N., & Hellström, K. E. (2003). The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Research, 63(13), 3695–3700.
   PubMed Web of Science ®Google Scholar
• Honda, H., Pazin, M. J., D'Souza, T., Ji, H., & Morin, P. J. (2007). Regulation of the CLDN3 gene in ovarian cancer cells. Cancer Biology & Therapy, 6(11), 1733–1742.
   PubMed Web of Science ®Google Scholar
• Hong, S., Dong, H., Jin, L., & Xiong, M. (2011). Gene co-expression network and functional module analysis of ovarian cancer. International Journal of Computational Biology and Drug Design, 4(2), 147–164.
   PubMedGoogle Scholar
• Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., Berkowitz, R. S., Muto, M. G., & Crum, C. P. (2007). Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. The American Journal of Surgical Pathology, 31(2), 161–169. https://doi.org/10.1097/01.pas.0000213335.40358.47
   PubMed Web of Science ®Google Scholar
• King, H. C., & Sinha, A. A. (2001). Gene expression profile analysis by DNA microarrays: Promise and pitfalls. JAMA, 286(18), 2280–2288.
   PubMed Web of Science ®Google Scholar
• Kotlyar, M., Pastrello, C., Sheahan, N., & Jurisica, I. (2016). Integrated interactions database: Tissue-specific view of the human and model organism interactomes. Nucleic Acids Research, 44(D1), D536–D541.
   PubMed Web of Science ®Google Scholar
• Kumar, S. U., Kumar, D. T., Siva, R., Doss, C. G. P., & Zayed, H. (2019). Integrative bioinformatics approaches to map potential novel genes and pathways involved in ovarian cancer. Frontiers in Bioengineering and Biotechnology, 7, 391. https://doi.org/10.3389/fbioe.2019.00391
   PubMed Web of Science ®Google Scholar
• Lee, H. J., Hwang, M., Chattopadhyay, S., Choi, H. S., & Lee, K. (2008). Hepatocyte nuclear factor-3 alpha (HNF-3α) negatively regulates androgen receptor transactivation in prostate cancer cells. Biochemical and Biophysical Research Communications, 367(2), 481–486.
   PubMed Web of Science ®Google Scholar
• Liang, J., Oyang, L., Rao, S., Han, Y., Luo, X., Yi, P., Lin, J., Xia, L., Hu, J., Tan, S., Tang, L., Pan, Q., Tang, Y., Zhou, Y., & Liao, Q. (2021). Rac1, a potential target for tumor therapy. Frontiers in Oncology, 11, 674426. https://doi.org/10.3389/fonc.2021.674426
   PubMed Web of Science ®Google Scholar
• Liu, R. Z., Vo, T. M., Jain, S., Choi, W. S., Garcia, E., Monckton, E. A., Mackey, J. R., & Godbout, R. (2019). NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer. The Journal of Pathology, 247(2), 186–198. https://doi.org/10.1002/path.5182
   PubMed Web of Science ®Google Scholar
• Mamoor, S. (2020). HLF is differentially expressed in high-grade serous ovarian cancers. OSF Preprints. https://doi.org/10.31219/osf.io/y534a.
   Google Scholar
• Martinez-Morales, J. R., Signore, M., Acampora, D., Simeone, A., & Bovolenta, P. (2001). Otx genes are required for tissue specification in the developing eye. Oxford University Press for The Company of Biologists Limited.
   Google Scholar
• Masoumi-Moghaddam, S., Amini, A., Ehteda, A., Wei, A. Q., & Morris, D. L. (2014). The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells. Journal of Ovarian Research, 7, 61. https://doi.org/10.1186/1757-2215-7-61
   PubMed Web of Science ®Google Scholar
• Matulonis, U. A., Sood, A. K., Fallowfield, L., Howitt, B. E., Sehouli, J., & Karlan, B. Y. (2016). Ovarian cancer. Nature Reviews. Disease Primers, 2, 16061. https://doi.org/10.1038/nrdp.2016.61
   PubMed Web of Science ®Google Scholar
• Menon, U., Ryan, A., Kalsi, J., Gentry-Maharaj, A., Dawnay, A., Habib, M., Apostolidou, S., Singh, N., Benjamin, E., Burnell, M., Davies, S., Sharma, A., Gunu, R., Godfrey, K., Lopes, A., Oram, D., Herod, J., Williamson, K., Seif, M. W., … Jacobs, I. (2015). Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Journal of Clinical Oncology, 33(18), 2062–2071. https://doi.org/10.1200/JCO.2014.59.4945
   PubMed Web of Science ®Google Scholar
• Moore, R. G., Hill, E. K., Horan, T., Yano, N., Kim, K., MacLaughlan, S., Lambert-Messerlian, G., Tseng, Y. D., Padbury, J. F., Miller, M. C., Lange, T. S., & Singh, R. K. (2014). HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Scientific Reports, 4, 3574. https://doi.org/10.1038/srep03574
   PubMed Web of Science ®Google Scholar
• Nonaka, D., Chiriboga, L., & Soslow, R. A. (2008). Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. The American Journal of Surgical Pathology, 32(10), 1566–1571. https://doi.org/10.1097/PAS.0b013e31816d71ad
   PubMed Web of Science ®Google Scholar
• Otto, T., & Sicinski, P. (2017). Cell cycle proteins as promising targets in cancer therapy. Nature Reviews Cancer, 17(2), 93–115. https://doi.org/10.1038/nrc.2016.138
   PubMed Web of Science ®Google Scholar
• Pan, T., Mao, T., Yang, H., Wang, H., & Wang, Y. (2018). Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis. Experimental and Therapeutic Medicine, 15(3), 2978–2984.
   PubMed Web of Science ®Google Scholar
• Pan, M. G., Xiong, Y., & Chen, F. (2013). NFAT gene family in inflammation and cancer. Current Molecular Medicine, 13(4), 543–554.
   PubMed Web of Science ®Google Scholar
• Pentheroudakis, G., & Pavlidis, N. (2010). Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Critical Reviews in Oncology/Hematology, 75(1), 27–42. https://doi.org/10.1016/j.critrevonc.2009.10.003
   PubMed Web of Science ®Google Scholar
• Petitjean, A., Achatz, M. I., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007). TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene, 26(15), 2157–2165. https://doi.org/10.1038/sj.onc.1210302
   PubMed Web of Science ®Google Scholar
• Pierini, S., Tanyi, J. L., Simpkins, F., George, E., Uribe-Herranz, M., Drapkin, R., Burger, R., Morgan, M. A., & Facciabene, A. (2020). Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight, 5(16). https://doi.org/10.1172/jci.insight.136773
   Google Scholar
• Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L., & Sellers, W. R. (2002). A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell, 2(1), 81–91.
   PubMed Web of Science ®Google Scholar
• Ranjan, N., Pandey, V., Panigrahi, M. K., Klumpp, L., Naumann, U., & Babu, P. P. (2021). The tumor suppressor MTUS1/ATIP1 modulates tumor promotion in glioma: Association with epigenetics and DNA repair. Cancers, 13(6), 1245. https://doi.org/10.3390/cancers13061245
   PubMed Web of Science ®Google Scholar
• Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011). Mutations in the p53 tumor suppressor gene: Important milestones at the various steps of tumorigenesis. Genes & Cancer, 2(4), 466–474. https://doi.org/10.1177/1947601911408889
   PubMedGoogle Scholar
• Rizzolio, S., & Tamagnone, L. (2007). Semaphorin signals on the road to cancer invasion and metastasis. Cell Adhesion & Migration, 1(2), 62–68. https://doi.org/10.4161/cam.1.2.4570
   PubMed Web of Science ®Google Scholar
• Rodgers, L. H., Ó hAinmhire, E., Young, A. N., & Burdette, J. E. (2016). Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Oncotarget, 7(22), 32785–32795. https://doi.org/10.18632/oncotarget.9051
   PubMedGoogle Scholar
• Rodriguez-Esteban, R., & Jiang, X. (2017). Differential gene expression in disease: A comparison between high-throughput studies and the literature. BMC Medical Genomics, 10(1), 1–10. https://doi.org/10.1186/s12920-017-0293-y
   PubMedGoogle Scholar
• Sahai, E., & Marshall, C. J. (2002). RHO-GTPases and cancer. Nature Reviews Cancer, 2(2), 133–142. https://doi.org/10.1038/nrc725
   PubMed Web of Science ®Google Scholar
• Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., Chakravarty, D., Daian, F., Gao, Q., Bailey, M. H., Liang, W.-W., Foltz, S. M., Shmulevich, I., Ding, L., Heins, Z., … Schultz, N., Cancer Genome Atlas Research Network (2018). Oncogenic signaling pathways in the cancer genome atlas. Cell, 173(2), 321–337.
   PubMed Web of Science ®Google Scholar
• Schug, Z. T., Voorde, J. V., & Gottlieb, E. (2016). The metabolic fate of acetate in cancer. Nature Reviews Cancer, 16(11), 708–717.
   PubMed Web of Science ®Google Scholar
• Shah, N. R., Tancioni, I., Ward, K. K., Lawson, C., Chen, X. L., Jean, C., Sulzmaier, F. J., Uryu, S., Miller, N. L., Connolly, D. C., & Schlaepfer, D. D. (2014). Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer. Gynecologic Oncology, 134(1), 104–111. https://doi.org/10.1016/j.ygyno.2014.04.044
   PubMed Web of Science ®Google Scholar
• Sticht, C., De La Torre, C., Parveen, A., & Gretz, N. (2018). miRWalk: An online resource for prediction of microRNA binding sites. PLoS One, 13(10), e0206239. https://doi.org/10.1371/journal.pone.0206239
   PubMed Web of Science ®Google Scholar
• Su, H., & Lau, Y. F. (1993). Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. American Journal of Human Genetics, 52(1), 24.
   PubMed Web of Science ®Google Scholar
• Tamagnone, L. (2012). Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell, 22(2), 145–152. https://doi.org/10.1016/j.ccr.2012.06.031
   PubMed Web of Science ®Google Scholar
• Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. 02 July (2019). GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47(W1), W556–W560. https://doi.org/10.1093/nar/gkz430
   PubMed Web of Science ®Google Scholar
• Tran, T. H., & Montano, M. A. (2017). MicroRNAs: Mirrors of health and disease. In Translating microRNAs to the clinic (pp. 1–15). Academic Press.
   Google Scholar
• Tzfadia, O., Diels, T., De Meyer, S., Vandepoele, K., Aharoni, A., & Van de Peer, Y. (2015). CoExpNetViz: Comparative co-expression networks construction and visualization tool. Frontiers in Plant Science, 6, 1194. https://doi.org/10.3389/fpls.2015.01194
   PubMed Web of Science ®Google Scholar
• Udhaya Kumar, S., Thirumal Kumar, D., Bithia, R., Sankar, S., Magesh, R., Sidenna, M., George Priya Doss, C., & Zayed, H. (2020). Analysis of differentially expressed genes and molecular pathways in familial hypercholesterolemia involved in atherosclerosis: A systematic and bioinformatics approach. Frontiers in Genetics, 11, 734. https://doi.org/10.3389/fgene.2020.00734
   PubMed Web of Science ®Google Scholar
• Van Nieuwenhuysen, E., Lambrechts, S., Lambrechts, D., Leunen, K., Amant, F., & Vergote, I. (2013). Genetic changes in nonepithelial ovarian cancer. Expert Review of Anticancer Therapy, 13(7), 871–882.
   PubMed Web of Science ®Google Scholar
• Washah, H. N., Salifu, E. Y., Soremekun, O., Elrashedy, A. A., Munsamy, G., Olotu, F. A., & Soliman, M. (2020). Integrating bioinformatics strategies in cancer immunotherapy: Current and future perspectives. Combinatorial Chemistry & High Throughput Screening, 23(8), 687–698. https://doi.org/10.2174/1386207323666200427113734
   PubMed Web of Science ®Google Scholar
• Yan, L., He, Z., Li, W., Liu, N., & Gao, S. (2021). The overexpression of acyl-CoA medium-chain synthetase-3 (ACSM3) suppresses the ovarian cancer progression via the inhibition of integrin β1/AKT signaling pathway. Frontiers in Oncology, 11.
   Web of Science ®Google Scholar
• Yang, Z., Wu, L., Wang, A., Tang, W., Zhao, Y., Zhao, H., & Teschendorff, A. E. (2017). dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers. Nucleic Acids Research, 45(D1), D812–D818.
   PubMed Web of Science ®Google Scholar
• Yu, X., Jin, J., Zheng, Y., Zhu, H., Xu, H., Ma, J., Lan, Q., Zhuang, Z., Chen, C. C., & Li, M. (2021). GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway. Cell Death & Disease, 12(2), 203. https://doi.org/10.1038/s41419-021-03492-3
   PubMed Web of Science ®Google Scholar
• Zaret, K. S., & Carroll, J. S. (2011). Pioneer transcription factors: Establishing competence for gene expression. Genes & Development, 25(21), 2227–2241. https://doi.org/10.1101/gad.176826.111
   PubMed Web of Science ®Google Scholar
• Zechel, C. (2005). The germ cell nuclear factor (GCNF). Molecular Reproduction and Development, 72(4), 550–556. https://doi.org/10.1002/mrd.20377
   PubMed Web of Science ®Google Scholar
• Zhang, B., & Horvath, S. (2005). A general framework for weighted gene co-expression network analysis. Statistical Applications in Genetics and Molecular Biology, 4(1), 1-45. https://doi.org/10.2202/1544-6115.1128
   PubMedGoogle Scholar
• Zhang, L., Yang, N., Huang, J., Buckanovich, R. J., Liang, S., Barchetti, A., Vezzani, C., O'Brien-Jenkins, A., Wang, J., Ward, M. R., Courreges, M. C., Fracchioli, S., Medina, A., Katsaros, D., Weber, B. L., & Coukos, G. (2005). Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Research, 65(3), 925–932.
   PubMed Web of Science ®Google Scholar
• Zhang, R., Zhang, S., Xing, R., & Zhang, Q. (2019). High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients. Thoracic Cancer, 10(10), 1953–1961. https://doi.org/10.1111/1759-7714.13174
   PubMed Web of Science ®Google Scholar
• Zhang, N., Zhao, Z., Long, J., Li, H., Zhang, B., Chen, G., Li, X., Lv, T., Zhang, W., Ou, X., Xu, A., & Huang, J. (2017). Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncology Reports, 38(6), 3650–3658.
   PubMed Web of Science ®Google Scholar